Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 125

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Expanded Glucose Import Capability Affords Staphylococcus aureus Optimized Glycolytic Flux during Infection

Vitko, Nicholas P., Grosser, Melinda R., Khatri, Dal, Lance, Thurlow R., Richardson, Anthony R. · 2016 · mBio

Abstract

Acquisition of numerous virulence determinants affords Staphylococcus aureus greater pathogenicity than other skin-colonizing staphylococci in humans. Additionally, the metabolic adaptation of S. aureus to nonrespiratory conditions encountered during infection (e.g., hypoxia, nitric oxide, iron chelation) has been implicated as contributing to S. aureus virulence. Specifically, S. aureus has been shown to ferment glycolytic substrates in nonrespiratory environments encountered within the host. Here, we show that S. aureus has acquired unique carbohydrate transporters that facilitate the maximal uptake of host sugars and serve to support nonrespiratory growth in inflamed tissue. The carbohydrate substrates of 11 S. aureus transporters were identified, and at least four of their genes encode S. aureus glucose transporters ( glcA , glcB , glcC , and glcU ). Moreover, two transporter genes ( glcA and glcC ) are unique to S. aureus and contribute disproportionately to the nonrespiratory growth of S. aureus on glucose. Targeted inactivation of sugar transporters reduced glucose uptake and attenuated S. aureus in a murine model of skin and soft tissue infections. These data expand the evidence for metabolic adaptation of S. aureus to invasive infection and demonstrate the specific requirement for the fermentation of glucose over all other available carbohydrates. Ultimately, acquisition of foreign genes allows S. aureus to adopt a metabolic strategy resembling that of infiltrating host immune cells: high glycolytic flux coupled to lactate excretion. IMPORTANCE The bacterial pathogen Staphylococcus aureus causes a wide range of human infections that are costly and difficult to treat. S. aureus differs from closely related commensal staphylococci in its ability to flourish following the invasion of deeper tissue from the skin surface. There, S. aureus primarily uses glucose to grow under respiration-limiting conditions imposed by the immune system. It was previously unclear how S. aureus thrives in this environment when other Staphylococcus species cannot. Our results provide evidence that S. aureus has acquired an expanded repertoire of carbohydrate transporters. In particular, four glucose transporters contribute to efficient S. aureus growth during infection. Thus, S. aureus has evolved to maximize its glucose uptake abilities for enhanced glycolytic flux during tissue invasion. This dependence on glucose acquisition for S. aureus virulence may also explain links between serious infectious complications associated with diabetic patients exhibiting elevated blood glucose levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.00296-16

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 S. aureus displays better anaerobic growth than CoNS. Anaerobic growth of S. aureus (SA) COL and LAC, S. epidermidis (SE) RP62A, S. haemolyticus (SH) ATCC 29970, and S. saprophyticus (SS) ATCC 15305 in TSB (A) and CDM plus 25 mM glucose (C) (n = 3). Corresponding average growth rates for TSB and CDM plus glucose are displayed in panels B and D, respectively (n = 3; error bars show the pooled standard error of the mean). Growth rates were calculated from 2 to 4 h (S. aureus LAC) and 3 to 5 h (S. aureus COL, S. epidermidis, S. haemolyticus, and S. saprophyticus) in TSB and from 2 to 8 h in CDM plus 25 mM glucose. Statistical significance was calculated with a Student two-sided t test (***, P ≤ 0.001). Abs, absorbance.
FIG 1 S. aureus displays better anaerobic growth than CoNS. Anaerobic growth of S. aureus (SA) COL and LAC, S. epidermidis (SE) RP62A, S. haemolyticus (SH) ATCC 29970, and S. saprophyticus (SS) ATCC 15305 in TSB (A) and CDM plus 25 mM glucose (C) (n = 3). Corresponding average growth rates for TSB and CDM plus glucose are displayed in panels B and D, respectively (n = 3; error bars show the pooled standard error of the mean). Growth rates were calculated from 2 to 4 h (S. aureus LAC) and 3 to 5 h (S. aureus COL, S. epidermidis, S. haemolyticus, and S. saprophyticus) in TSB and from 2 to 8 h in CDM plus 25 mM glucose. Statistical significance was calculated with a Student two-sided t test (***, P ≤ 0.001). Abs, absorbance.CC BY · PubMed Central
FIG 2 S. aureus Encodes enhanced carbohydrate transport capability. Shown is a Venn diagram depicting the presence and conservation of putative carbohydrate transport proteins in the genomes of S. aureus COL, S. epidermidis RP62A, S. haemolyticus JCSC1435, and S. saprophyticus ATCC 15305. S. aureus encodes more overall transporters (n = 22) and the highest number of unique transporters not found in any of the other species (n = 10).
FIG 2 S. aureus Encodes enhanced carbohydrate transport capability. Shown is a Venn diagram depicting the presence and conservation of putative carbohydrate transport proteins in the genomes of S. aureus COL, S. epidermidis RP62A, S. haemolyticus JCSC1435, and S. saprophyticus ATCC 15305. S. aureus encodes more overall transporters (n = 22) and the highest number of unique transporters not found in any of the other species (n = 10).CC BY · PubMed Central
FIG 3 PTS-dependent carbohydrate uptake contributes disproportionately to the nonrespiratory growth of S. aureus. (A) Glucose yield (milligrams of glucose consumed per milligram [dry weight] of biomass) of S. aureus COL under respiratory and nonrespiratory (anaerobic and NO-stressed) conditions (n = 3; error bars show the standard error of the mean). S. aureus consumes ~3-fold more glucose per cell under nonrespiratory conditions. Statistical significance was calculated with a Student two-sided t test (*, P ≤ 0.01). (B to E) Growth curves of WT and PTS-deficient (ptsH-H15A) S. aureus LAC in TSB under aerobic (B), anaerobic (C), NO-stressed (D), and metal-limiting (E) conditions (n = 3). Abs, absorbance.
FIG 3 PTS-dependent carbohydrate uptake contributes disproportionately to the nonrespiratory growth of S. aureus. (A) Glucose yield (milligrams of glucose consumed per milligram [dry weight] of biomass) of S. aureus COL under respiratory and nonrespiratory (anaerobic and NO-stressed) conditions (n = 3; error bars show the standard error of the mean). S. aureus consumes ~3-fold more glucose per cell under nonrespiratory conditions. Statistical significance was calculated with a Student two-sided t test (*, P ≤ 0.01). (B to E) Growth curves of WT and PTS-deficient (ptsH-H15A) S. aureus LAC in TSB under aerobic (B), anaerobic (C), NO-stressed (D), and metal-limiting (E) conditions (n = 3). Abs, absorbance.CC BY · PubMed Central
FIG 4 Contributions of the identified glucose transporters to the nonrespiratory growth of S. aureus. (A) Aerobic growth of WT and selected double, triple, and quadruple S. aureus COL glucose transporter mutants in CDM plus 25 mM glucose (n = 3). (B) Representative aerobic growth curve demonstrating complementation of S. aureus COL ΔG4 mutant growth in CDM plus 25 mM glucose by each individual glucose transporter (n = 3). (C) Percent [U-14C]glucose uptake by S. aureus COL ΔG4 relative to that of the WT, as well as ΔG4 complemented with each individual glucose transporter gene. Uptake by each strain was measured following 12 min of incubation with radiolabeled substrate and then normalized to that of the WT (n = 4; error bars show the standard error of the mean). Statistical significance was calculated with a Student two-sided t test (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (D and E) Nonrespiratory growth rate of S. aureus COL ΔG4, relative to that of the WT, compared to that of mutants expressing individual transporter genes from their native promoters. Strains were cultured anaerobically (D) or under NO stress (10 mM NOC-12–1 mM DEA-NO) (E) (n = 3; error bars show the pooled standard error of the mean). Statistical significance was calculated with a Student two-sided t test (**, P ≤ 0.01; ***, P ≤ 0.001). Abs, absorbance.
FIG 4 Contributions of the identified glucose transporters to the nonrespiratory growth of S. aureus. (A) Aerobic growth of WT and selected double, triple, and quadruple S. aureus COL glucose transporter mutants in CDM plus 25 mM glucose (n = 3). (B) Representative aerobic growth curve demonstrating complementation of S. aureus COL ΔG4 mutant growth in CDM plus 25 mM glucose by each individual glucose transporter (n = 3). (C) Percent [U-14C]glucose uptake by S. aureus COL ΔG4 relative to that of the WT, as well as ΔG4 complemented with each individual glucose transporter gene. Uptake by each strain was measured following 12 min of incubation with radiolabeled substrate and then normalized to that of the WT (n = 4; error bars show the standard error of the mean). Statistical significance was calculated with a Student two-sided t test (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (D and E) Nonrespiratory growth rate of S. aureus COL ΔG4, relative to that of the WT, compared to that of mutants expressing individual transporter genes from their native promoters. Strains were cultured anaerobically (D) or under NO stress (10 mM NOC-12–1 mM DEA-NO) (E) (n = 3; error bars show the pooled standard error of the mean). Statistical significance was calculated with a Student two-sided t test (**, P ≤ 0.01; ***, P ≤ 0.001). Abs, absorbance.CC BY · PubMed Central
FIG 5 S. aureus glucose transporter mutants show attenuated virulence in a murine SSTI model. (A) Abscess burdens on day 5 following the subcutaneous injection of 1 × 107 CFU of S. aureus LAC (5 ≤ n ≤ 17; error bars show the standard error of the mean). Statistical significance was determined by analysis of variance with multiple comparisons (*, P ≤ 0.05). (B) Lesion sizes following the subcutaneous injection of 1 × 108 CFU of S. aureus LAC (5 ≤ n ≤ 10; error bars show the standard error of the mean). (C) Immunohistochemistry with antibodies against Hypoxyprobe adduct demonstrating the slow progression of abscess tissue from relatively aerobic conditions at early time points toward hypoxic conditions at later time points.
FIG 5 S. aureus glucose transporter mutants show attenuated virulence in a murine SSTI model. (A) Abscess burdens on day 5 following the subcutaneous injection of 1 × 107 CFU of S. aureus LAC (5 ≤ n ≤ 17; error bars show the standard error of the mean). Statistical significance was determined by analysis of variance with multiple comparisons (*, P ≤ 0.05). (B) Lesion sizes following the subcutaneous injection of 1 × 108 CFU of S. aureus LAC (5 ≤ n ≤ 10; error bars show the standard error of the mean). (C) Immunohistochemistry with antibodies against Hypoxyprobe adduct demonstrating the slow progression of abscess tissue from relatively aerobic conditions at early time points toward hypoxic conditions at later time points.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. 10.7326/0003-4819-144-5-200603070-00006 · DOI · Paper page
  2. 10.1016/j.annemergmed.2010.11.024 · DOI
  3. 10.1001/jama.290.22.2976 · DOI · Paper page
  4. 10.1016/j.ijantimicag.2009.03.004 · DOI
  5. 10.1093/infdis/143.4.509 · DOI · Paper page
  6. 10.1128/CMR.00109-13 · DOI · Paper page
  7. 10.1128/IAI.70.9.4987-4996.2002 · DOI · Paper page
  8. 10.1016/S0966-842X(98)01400-0 · DOI · Paper page
  9. 10.1016/j.mib.2013.11.004 · DOI · Paper page
  10. 10.1016/j.tiv.2010.06.016 · DOI · Paper page
  11. 10.1371/journal.pone.0016957 · DOI · Paper page
  12. 10.1371/journal.pone.0028824 · DOI
  13. 10.1016/j.chom.2012.11.012 · DOI · Paper page
  14. 10.1128/mBio.00045-15 · DOI · Paper page
  15. 10.1186/gb-2009-10-6-r63 · DOI · Paper page
  16. Dills SS, Apperson A, Schmidt MR, Saier MH. 1980. Carbohydrate transport in bacteria. Microbiol Res 44:385–418.
  17. 10.1128/MR.57.3.543-594.1993 · doi:10.1128/mr.57.3.543-594.1993 · Paper page
  18. 10.1016/S1389-1723(01)80308-X · DOI · Paper page
  19. 10.1086/431587 · DOI · Paper page
  20. 10.1016/0304-4165(65)90096-6 · doi:10.1016/0304-4165(65)90096-6
  21. 10.1128/mBio.00537-12 · DOI · Paper page
  22. 10.1007/s00018-014-1635-y · DOI
  23. 10.1111/j.1365-2958.2008.06564.x · DOI
  24. 10.1046/j.1432-1327.2001.02265.x · DOI · Paper page
  25. 10.1016/j.jdiacomp.2007.07.003 · doi:10.1016/j.jdiacomp.2007.07.003
  26. 10.1080/00365540600617017 · DOI
  27. 10.1126/science.1250684 · DOI · Paper page
  28. 10.1186/1471-2180-9-95 · DOI · Paper page
  29. 10.1128/IAI.00035-08 · DOI · Paper page
  30. 10.1128/IAI.00724-08 · DOI
  31. 10.1128/iai.6.5.689-694.1972 · doi:10.1128/iai.6.5.689-694.1972
  32. 10.1128/iai.60.8.3381-3388.1992 · DOI · Paper page
  33. 10.1074/jbc.M505070200 · DOI · Paper page
  34. 10.1128/JB.187.23.8181-8184.2005 · DOI
  35. 10.1128/mBio.00241-13 · DOI · Paper page
  36. 10.1111/mmi.13347 · DOI
  37. 10.1128/mBio.00696-13 · DOI · Paper page
  38. 10.1111/j.1365-2958.2008.06363.x · DOI · Paper page
  39. 10.1161/01.CIR.0000124719.61827.7F · DOI · Paper page
  40. 10.1007/s00125-010-1672-5 · DOI · Paper page
  41. 10.1016/j.bmc.2014.01.020 · DOI
  42. 10.1002/9780471729259.mc09c02s28 · DOI
  43. 10.1371/journal.pone.0054293 · DOI

Cited by

See all 125

Metadata

Authors
Vitko, N. P., Grosser, M. R., Khatri, D., Lance, T. R., & Richardson, A. R.
Affiliations
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Venue
mBio
Published
2016-07-06
Volume
7
Issue
3
ISSN
  • 2161-2129
  • 2150-7511
Cited by
125
References
6
Language
en
Licence
Funders
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01-AI093613, R21-AI111707)
  • American Heart Association (13PRE15200002, 13PRE19830003)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.